In previous studies, we have used a syngeneic ENU-induced rat glioma model (RG2) to investigate synergistic effects of hypo-fractionated radiation therapy in conjunction with IDO-inhibitory 1-DL-Methyl tryptophan (1-MT) treatment for GBM. This evidence concerns the gene IDO1 and glioblastoma.